Leukine, OXALIPLATIN, ENDOXAN 50 mg, comprimé enrobé, STC-1010, FLUOROURACIL, CALCIUM FOLINATE
BreAK CRC 001
Phase 2 small_molecule active
Quick answer
Leukine, OXALIPLATIN, ENDOXAN 50 mg, comprimé enrobé, STC-1010, FLUOROURACIL, CALCIUM FOLINATE for Unresectable locally advanced or metastatic colorectal cancer is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Unresectable locally advanced or metastatic colorectal cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active